| The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours |
29 |
| Statin drugs to reduce breast cancer recurrence and mortality |
26 |
| Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer |
23 |
| Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation |
23 |
| Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein(MVP) |
22 |
| Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research |
22 |
| Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy |
21 |
| Updating the role of obesity and cholesterol in breast cancer |
21 |
| Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies |
20 |
| CD CD and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers |
20 |
| BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer |
19 |
| Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial |
19 |
| Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer |
18 |
| The lncRNA MIR2052HG regulates ER alpha levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1 |
18 |
| A comparison of five methods of measuring mammographic density: a case-control study |
18 |
| Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models |
17 |
| Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment |
17 |
| Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population |
16 |
| GSK3 regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer |
15 |
| The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells |
15 |
| Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery |
14 |
| Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial |
14 |
| Obesity promotes the expansion of metastasis-initiating cells in breast cancer |
14 |
| Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis |
13 |
| Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population |
13 |
| Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98 |
13 |
| Immune characterization of breast cancer metastases: prognostic implications |
13 |
| Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment |
13 |
| Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis |
13 |
| Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients |
12 |
| Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer |
12 |
| MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors |
12 |
| Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis |
12 |
| Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression |
12 |
| Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study |
12 |
| Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth |
12 |
| Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer |
12 |
| Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression |
12 |
| Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes |
12 |
| Vitamin D receptor expression in invasive breast tumors and breast cancer survival |
12 |
| Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer |
11 |
| Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3 activities |
11 |
| Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study |
11 |
| Effect of exercise and/or reduced calorie dietary interventions on breast cancer-related endogenous sex hormones in healthy postmenopausal women |
11 |
| Impact of obesity on breast cancer recurrence and minimal residual disease |
11 |
| Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases |
11 |
| Vitamin D, DNA methylation, and breast cancer |
11 |
| The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers |
11 |
| Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics |
10 |
| Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype |
10 |
